BioSpace News Archive

KAZIA THERAPEUTICS TO PARTICIPATE IN EDISON GROUP’S GLOBAL HEALTHCARE ‘OPEN HOUSE’ VIRTUAL CONFERENCE

Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be speaking at the Edison Group ‘Open House’ Event, to be held virtually from 25-27 January 2022.

January 25, 2022
·
3 min read
Business

Tony O’Neill Joins Ajinomoto Bio-Pharma Services’ Leadership Team as Vice President of Compliance

Ajinomoto Bio-Pharma Services, a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations.

January 25, 2022
·
2 min read
Business

Melzi Surgical Appoints Financial Industry Executive, Michael Layman to Board of Directors

Melzi Surgical announced today the appointment of Michael Layman to its Board of Directors.

January 25, 2022
·
3 min read
Business

Immunovant Appoints Mark Levine as Chief Legal Officer

Immunovant, Inc announced the appointment of Mark Levine as Chief Legal Officer.

January 25, 2022
·
5 min read
Biotech Beach

Thermo Fisher Scientific Earns NSF/ANSI 456 Vaccine Storage Certification for its High-Performance Refrigerators and Freezers

Thermo Scientific TSX and TSG Series meet stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for COVID-19.

January 25, 2022
·
3 min read
Drug Development

Cartesian Therapeutics Doses Patient with First Allogeneic RNA Cell Therapy for Multiple Myeloma

Cartesian Therapeutics today announced that it has dosed the first patient in a Phase 1/2a multicenter clinical study evaluating Descartes-25 in patients with multiple myeloma.

January 25, 2022
·
4 min read
Business

AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies

AmerisourceBergen today unveiled an integrated technology platform designed to accelerate patient access to prescribed cell and gene therapies and deliver complete visibility throughout the treatment journey.

January 25, 2022
·
5 min read
Chinese Medical Journal Review Delves into Helicobacter pylori Treatment

Helicobacter pylori (H. pylori) is one of the most common pathogens associated with gastric and extra-gastric disorders. H. pylori infection affects around half of the world’s population, yet its prevalence varies across the globe

January 25, 2022
·
2 min read
Business

Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014

Mindset Pharma Inc. today announced that it has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO) for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug candidate, MSP-1014.

January 25, 2022
·
3 min read
Biotech Beach

Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate

Aurora Spine Corporation announced today that the first anterior cervical discectomy and fusion procedures were completed with its proprietary APOLLO TM Anterior Cervical Plate (ACP) system.

January 25, 2022
·
5 min read